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ABSTRACT  The  whole-cell  patch-clamp  technique  was  used  to  study  voltage- 
dependent calcium currents in primary cultures of myotubes and in freshly disso- 
ciated skeletal muscle from normal and dysgenic mice. In addition to the transient, 
dihydropyridine  (DHP)-insensitive  calcium current  previously described,  a  main- 
tained DHP-sensitive calcium current was found in dysgenic skeletal muscle. This 
current, here termed  Ic~,t,, is largest in acutely dissociated fetal or neonatal dys- 
genic muscle and also in dysgenic myotubes grown on a  substrate of killed fibro- 
blasts.  In dysgenic myotubes grown on untreated  plastic  culture  dishes,  Ic~  is 
usually so small that it cannot be detected.  In addition,  Ic~ay, is apparently absent 
from normal skeletal muscle. From a holding potential of -80  mV, Ic~.,a becomes 
apparent for test pulses to ~- 20 mV and peaks at ~ + 20 mV. The current acti- 
vates rapidly (rise time ~5 ms at 20~  and with 10 mM Ca as charge cattier inac- 
tivates  little  or not at all during a  200-ms test  pulse.  Thus,  Ic~.,~ activates much 
faster  than  the  slowly activating calcium current  of normal  skeletal  muscle  and 
does not display Ca-dependent inactivation like the cardiac L-type calcium current. 
Substituting Ba for Ca as the charge carrier doubles the size of Ic~.d~ without alter- 
ing its kinetics. Ic,.,a is ~75% blocked by 100 nM (+)-PN 200-110 and is increased 
about threefold by 500 nM racemic Bay K 8644. The very high sensitivity of Ic~.ay, 
to these DHP compounds distinguishes  it from neuronal  L-type calcium current 
and from the calcium currents of normal  skeletal  muscle.  Ic~.d~ may represent  a 
calcium channel  that is normally not expressed  in skeletal  muscle, or a  mutated 
form of the skeletal muscle slow calcium channel. 
INTRODUCTION 
Vertebrate  cell membranes contain a variety of voltage-gated calcium channels that 
are  categorized  according  to  voltage  dependence,  kinetics,  and  pharmacology 
(Bean,  1989).  To  date,  skeletal  muscle  has  been  shown  to  express  three  distinct 
types of calcium currents.  These  are  (a)  a  fast-activating,  transient  current  that  is 
insensitive to 1,4-dihydropyridine (DHP) derivatives (Beam et al.,  1986; Cognard et 
al.,  1986a; Beam and Knudson, 1988; Gonoi and Hasegawa,  1988); (b) a fast-activat- 
ing,  maintained  current  that  is  also  DHP-insensitive  (Cota  and  Stefani,  1986; 
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Arreola et al.,  1987;  Garcia et al.,  1988); and (c) a  slowly-activating current  that is 
DHP-sensitive  (Donaldson  and  Beam,  1983;  Beam  et  al.,  1986;  Cognard  et  al., 
1986a and b; Beam and Knudson,  1988; Gonoi and Hasegawa, 1988).  In this paper, 
we have adopted the following nomenclature for these different currents. The fast- 
activating, transient current is termed Ic~.a; this current is found in developing skel- 
etal  muscle,  and  resembles  the  T-type  (Nowycky  et  al.,  1985)  calcium  current 
reported for many different cell types (Bean,  1989). The fast-activating, maintained 
current  is termed Ic~-fm; this current  has been  described for frog and  mammalian 
skeletal muscle, and does not fit easily into the T, L  or N  categories of Nowycky et 
al.  (1985).  The slowly-activating current  is termed Ica-~; this current  is a  distinctive 
form of L-type calcium current characteristic of skeletal muscle. 
Ic~.~ is the dominant calcium current in normal skeletal muscle. However, in skel- 
etal muscle from mice with muscular dysgenesis,  Ic~ is absent (Beam et al.,  1986; 
Rieger  et  at.,  1987)  and  excitation-contraction  (E-C)  coupling  is  nonfunctional 
(Powell and Fambrough,  1973;  Klaus et al.,  1983).  Genetic analysis indicates  that 
the muscular dysgenesis mutation alters the structural gene for the alpha1 subunit of 
the skeletal muscle DHP receptor; injecting cDNA for this subunit into developing 
dysgenic myotubes restores both Ic~.~ and E-C coupling (Tanabe et al.,  1988). These 
results indicate that the alpha1 subunit of the DHP receptor is a necessary compo- 
nent of both the slow calcium channel and the E-C coupling mechanism. 
Grown under  standard  tissue culture  conditions,  myotubes from dysgenic mice 
express only a single prominent calcium current,  Ic~.ft (Beam et al.,  1986;  Rieger et 
al., 1987). However, in dysgenic skeletal muscle that has developed in vivo or under 
special  culture  conditions,  we  have observed an  additional  calcium current.  This 
current,  which  we  term  Ic~y,,  is  distinct,  both  kinetically  and  pharmacologically, 
from Ic~ and also from the other calcium currents found in skeletal muscle (Ica-ft, 
Ic~.fm). Ic~s does not appear to be present in normal skeletal muscle. 
In this paper we describe the kinetics, voltage dependence, and pharmacology of 
Ic~y~ in dysgenic skeletal muscle.  In addition,  we compare the properties of Ica~y~ 
with those of other known calcium currents, especially those found in normal skele- 
tal  muscle.  A  preliminary  account  of  some  of  the  results  presented  here  has 
appeared previously (Adams and Beam,  1989). 
METHODS 
Voltage Clamp 
Calcium currents were recorded using the whole-cell  variant of the patch-clamp technique 
(Hamill et al.,  1981).  Pipettes were fabricated from borosilicate glass and filled with an inter- 
nal solution containing (millimolar)  140 Cs-aspartate, 5 MgCI~, 10 Cs~EGTA, 10 Hepes, pH 
7.4 with CsOH. The resistance of the pipettes varied from 1.3 to 2.5 M-ohm. For each cell, 
the linear capacitative and leakage currents were measured for a depolarizing or hyperpolar- 
izing control pulse of 10-20 mV from a holding potential of -80 inV. The area beneath the 
capacitative transient and the time constant of the transient's decay were used to calculate the 
cell's linear capacitance and the series resistance associated with the pipette (Matteson and 
Armstrong,  1984).  Electronic  compensation was  used  to reduce  the  effective series resis- 
tance,  generally to a value <1.5  M-ohm. The control current described above was scaled 
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leakage currents. Test pulses were separated by an interval of at least 5 s. To allow compari- 
son of test currents recorded from different cells,  the current recorded from each cell was 
normalized by that cell's linear capacitance (current expressed as picoamperes per picofarad). 
In many of the illustrated traces, the first several data points after a change in potential have 
been blanked. Data were filtered at 500  Hz and sampled at  1,000  Hz.  Experiments were 
conducted at room temperature (20-22~  Average numerical values are presented in the 
text and figures as mean _+ SEM. 
External Solutions 
Calcium channel currents were recorded while the cells were bathed in an external solution 
containing (millimolar) 145 TEA-C1, 10 CaC12 [or 10 BaCI~], 10 Hepes, pH 7.4 with CsOH. 
In addition, all external solutions contained 2-10 I~M Trx, as required, to block voltage- 
gated sodium channels. 
Cell Culture 
Primary cultures of myoblasts were prepared from skeletal muscles of late-term fetal or new- 
born mice. The muscles were minced and then incubated at 37~  for 40-60 rain in Ca, Mg- 
free Ringer (155 mM NaCI, 5 mM KC1, 10 mM Hepes, pH 7.4 with NaOH) containing  0.25% 
(wt/vol) crude trypsin (1:250, Difco Laboratories Inc., Detroit, MI). After filtration and cen- 
trifugation to remove large debris, the cell suspension was plated at a density of 10  ~  cells/dish 
onto 35-ram Primaria dishes (Becton Dickinson Labware, Lincoln Park,  NJ)  containing an 
attached layer of killed fibroblasts (see below). The plating medium contained (vol/vol) 80% 
Dulbecco's modified Eagle's medium with 4.5 g/liter glucose (DMEM) and 20% fetal bovine 
serum.  After  3-5  d,  the  plating medium was  replaced  with  maintenance medium: 90% 
DMEM and 10% horse serum. All culture media contained penicillin  (100 U/ml) and strepto- 
mycin (100 ~g/ml). Cultures were maintained at 37~  in a 95% air/5% COs, water-saturated 
atmosphere. 
The substrate of killed fibroblasts was created by first growing fibroblasts to confluence on 
untreated culture dishes. The culture medium was  then removed and the fibroblasts were 
exposed to deionized water for  1 rain, followed by complete dessication under ultraviolet 
light for 15 rain. The resultant dishes, containing a layer of lysed and dessicated fibroblasts, 
were then stored at 4~  until use. Fibroblasts from three different sources (NIH 3T3 cell line; 
skin fibroblasts from dysgenic mice and their nondysgenic littermates) were used for this pur- 
pose. 
Acute Isolation  of Muscle Cells 
Single skeletal muscle fibers were dissociated from the plantar muscles (i.e., all the muscles on 
the sole of the hind foot) of fetal (day  15-20) or neonatal (1-2-d-old) mice following the 
procedure of Beam and Knudson (1988). 
Application of Drugs 
Concentrated (1 or 10 raM) stock solutions of the DHP compounds (+)-PN 200-110 (kindly 
provided by Dr. A. Lindenmann and Dr.  E.  Rossi of Sandoz Ltd., Basel,  Switzerland) and 
racemic  Bay  K  8644  (kindly supplied by Dr.  A.  Scriabine, Miles  Laboratories,  Inc., New 
Haven, CT) were prepared by dissolving the drugs in 100% ethanol. The stock solutions were 
stored in the dark at -20~  Test concentrations were prepared just before use by dilution 
with the external saline used for current measurement (final ethanol concentration, <0.01%). 
The microscope light was turned off and the room was darkened during application of these 
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The  effects  of  pharmacological  agents  or  ionic  substitution  were  examined  by  bulk 
exchange of the external medium with 10-20 times the bath volume of new medium. Because 
we found that simply replacing the bathing solution with a fresh, but identical solution tended 
to potentiate calcium currents,  the following procedure was adopted. After stable calcium 
currents had been recorded from a  given myotube or muscle fiber, the bath solution was 
replaced with identical external saline and currents were recorded both immediately and 5 
rain after this first "control" solution exchange. Next, the test solution (containing Cd, Ba, or 
drugs) was perfused through the chamber, and calcium currents were again measured imme- 
diately and after 5 min. Finally, the test solution was washed out of the chamber and calcium 
currents were once more recorded immediately and 5 min afterwards. 
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FIGURE  1.  Two  components 
of inward calcium current in a 
dysgenic skeletal muscle fiber. 
(A) Calcium currents were elic- 
ited by test pulses to the indi- 
cated  potentials from  a  hold- 
ing potential (HP) of -80 mV; 
the  HP  was  then  changed  to 
-40  mV for  100  s and a  sec- 
ond  series  of  currents  was 
obtained. A portion of the acti- 
vation  phase  of  the  currents 
elicited from  HP  =  -80  mV 
has been blanked to reveal the 
kinetics  of  current  elicited 
from HP =  -40 mV. (B) Cur- 
rent-voltage  relations  of  Ic~f, 
and  Ic~.~ in  dysgenic skeletal 
muscle. (Open symb0/s) Ic~ft, the difference between transient and maintained components of 
current elicited from HP =  -80  mV, (Solid symb0/s) Ic~,  current elicited from HP =  -40 
mV.  Cell B00M69,  acutely dissociated from the plantar muscles of a  fetal day 15 dysgenic 
mouse; capacitance (C) =  153 pF. 10 mM Ca  2+  +  2 #M TTX. 
RESULTS 
Two Calcium Currents  Are Present in Dysgenic  Skeletal Muscle 
Fig.  1  illustrates the  presence  of two  distinct calcium  currents  in  a  freshly disso- 
ciated muscle  fiber from  a  fetal  (day  15)  dysgenic mouse.  Fig.  1 A  shows  calcium 
currents  elicited from  holding  potentials  of  -80  and  -40  inV.  From  a  holding 
potential of -  80 mV, two components of inward current were observed, a transient 
component  and  a  maintained  component.  Changing  the  steady holding potential 
from  -80  to  -40  mV eliminated the transient component and left the maintained 
component  unaltered.  For  the  traces  shown,  the  holding  potential  was  changed 
from  -80  to -40  mV for 100 s; however, only brief prepulses (e.g., 1 s to -30  mV) 
were  required  to inactivate the  transient  component  (Beam and  Knudson,  1988). 
The  transient  component  corresponds  to  a  calcium  current  (Ic~f,)  previously 
described  for  developing  skeletal  muscle  from  both  normal  and  dysgenic  mice 
(Beam et al., 1986; Beam and Knudson,  1988; Gonoi and Hasegawa,  ! 988).  In con- ADAMS AND BEAM  Calcium  Current in Dysgenic Muscle  433 
trast,  the maintained component  (here termed Ic~m) does not correspond to any 
previously described calcium current of normal or dysgenic skeletal muscle. Fig.  1 B 
shows  the  peak current-voltage  relations  for the  calcium currents  Ic~.ft and  Ic~dy~ 
illustrated in Fig.  ] A.  It is clear from the plot that the two currents are activated 
over different ranges of transmembrane voltage. 
Ic~.d~ IS Mediated by Calcium Channels 
Ic.~m is evidently a  calcium current because with our recording conditions  Ca was 
the only inorganic ion available to carry inward current at depolarized test poten- 
tials. This interpretation is further supported by the observation that Ic~  was re- 
versibly reduced in amplitude by lowering the external Ca concentration (Fig. 2 A). 
In three dysgenic myotubes, the peak Ic~.~ measured in 2 mM Ca was only 52  -+ 3% 
of that measured in  10 mM Ca. In 2 mM external Ca the peak current-voltage rela- 
tion of Ic~.~ was shifted by ~-  20 mV compared to that in 10 mM external Ca. In 
addition, Ic~,~ was almost completely blocked by the application of 100 #M Cd (Fig. 
A 
2  Ca 
10  Ca 
B 
Cd 
Control 
100  ms 
<= 
eq 
Fmu~  2.  (A) The amplitude of Ic,,.~ depends 
upon external calcium concentration. Shown are 
the  peak calcium currents  recorded  in  external 
solution containing  2  or  10  mM Ca plus  2  #M 
Trx. Steady HP =  -80 mV; brief (1 s) prepulses 
to -60 mV (2 Ca) or -30 mV (10 Ca) were used 
to inactivate lca.tt.  Test pulses -10 mV (2 Ca) or 
+20  mV  (10  Ca).  Cell  B00F49,  dysgenic  myo- 
tube,  12 d  in culture; C  =  450 pF.  (B)  Ic~.~ is 
blocked by 100 #M external cadmium (Cd). Cell 
B00E71,  dysgenic myotube, 9 d  in culture;  C = 
1450 pF. HP =  -80 mV. Test pulses to +20 mV. 
10mMCa  ~+ +  4#MTTX. 
2 B). The effect of this concentration of Cd was completely reversible (n =  3; wash- 
out not shown). Furthermore, as discussed below, Ic~-,m  is quite sensitive to modula- 
tion by DHP compounds (Fig.  6). 
lc,.~ Is Larger when Barium Carries Charge 
Fig.  3  demonstrates the relative effectiveness of Ba and Ca as charge carriers for 
Ic~.  Substituting  10 mMBa  for 10 mM Ca in the external solution doubled the 
size of Ic~r~ without significantly altering its kinetics. This effect was very consistent 
and readily reversible for individual  myotubes (Fig.  3  shows Ca currents obtained 
before and after switching to external Ba). Altogether, in five dysgenic myotubes the 
peak current in 10 mM Ba was 203  •  13% of its magnitude in 10 mM Ca. In 10 mM 434 
~_  Ca 
,,  Sa 
100  ms 
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FIGURE 3.  IC,.~ is larger with Ba as charge car- 
der.  Shown are the peak currents recorded with 
external Ca (test pulses to + 20 mV) and external 
Ba  (test  pulse  to  0  mV).  The  external  solution 
contained 4 #M TTX +  10 mM Ca or 10 mM Ba. 
Cell B00B98, dysgenic myotube, 18 d in culture; 
C  =  680 pF. HP  =  -80 mV. 
external  Ba solution  the  peak  current-voltage  relation  for Ices  was  shifted  nega- 
tively 10-20 mV compared to that measured in  10 mM external  Ca. 
Ic,~ Is Distinct from the Slow Calcium Current of Normal Muscle 
How is this new current (Ic~.~) related to the slow calcium current (Ic~.s) of normal 
muscle? I~  and Ic~, have markedly different kinetics.  Fig. 4 compares the kinetics 
of Ic~  recorded from a dysgenic myotube with those of Ic~ recorded from a nor- 
mal  myotube.  The  currents  shown  were  elicited  from  steady  holding  potentials 
of-  40 or  -50  mV; thus,  Ica.ft is inactivated and Ic~  and Ic~ are shown in isola- 
tion.  Characteristically,  Ic~r~  activates  with  rapid  time-course  (time-to-peak  5-10 
ms)  and displays little  or no inactivation  for test pulses  lasting up  to 200  ms (Fig. 
4 A). In contrast, Ic~.s activates very slowly, with a  time-to-peak of 200-300 ms (Fig. 
4B). 
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FIGURE 4.  Ic~a~ and  Ic~ are 
kinetically distinct and also dif- 
fer  in  voltage-dependence  of 
activation.  (A)  I~,  m  recorded 
from a dysgenic myotube. Cell 
B00C90,  8  d  in  culture;  C  = 
260  pF.  HP  =  -40  mV.  (B) 
Ic~,  recorded  from  a  normal 
myotube. Cell B00B57, 11 d in 
culture;  C  =  260  pF.  HP  = 
-  50 mV. 
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Fig.  5  illustrates  average  current-voltage relations  for Ic~9  and  Ic~.,. The  plot 
summarizes data obtained from 13 dysgenic and 12 normal myotubes. From a hold- 
ing potential of -80  mV, Ic~  first becomes apparent for test pulses to ~-30  inV. 
In contrast,  Ic~.~ first appears for test pulses to ~-10  mV.  Ic~  peaks near  + 15 
mV, whereas [c~ peaks near + 25 inV. The voltage-dependence of inactivation also 
differs between Ic~,  and  Ic~.,. From a  steady holding potential of -80  mV,  30-s 
prepulses to -30,-20,-10,  and 0 mV inactivated Ic~., by 21  +  6, 49  _+ 7, 74  +  6, 
and 88 _+ 3% respectively (n =  12 normal neonatal fibers), but only inactivated Ic~y~ 
by 11  +  3,  22  -+  5, 44  _+  8, and  68  _+  10%, respectively (n =  6  dysgenic neonatal 
fibers). Thus,  Ic~.,~ activates over a  more negative range of membrane potentials 
(Figs.  4  and 5) and inactivates over a more positive range of membrane potentials 
than does Ic~,. 
It has previously been shown that Ic~., is blocked or potentiated by various DHP 
compounds  (Cognard et al.,  1986b; Lamb and Walsh,  1987;  Beam and Knudson, 
1988).  To  assess  the  relative  DHP-sensitivity  of  Ic~-dy,, calcium  currents  were 
recorded  from  normal  and  dysgenic  myotubes  in  the  absence  and  presence  of 
Test  (mY)  -60  +6O 
~Ca-dys 
.1.0  •  '-  Ca-s 
FIGURE 5.  Comparison of peak current-voltage 
relations for Ic~-dr, and Ic~,. The data shown are 
averages  of normalized  peak  I-V  relationships 
from 13 dysgenic and 12 normal myotubes. The 
normalized peak I-V for an individual  myotube 
was  obtained by dividing  the peak calcium cur- 
rent measured at each test potential by the maxi- 
mum calcium current recorded in that cell. The 
error bars  represent  :eSEM. For all  myotubes, 
HP =  -80 inV. 10 mM Ca  2+  +  4 pM TYX. 
(+)-PN  200-110,  an  inhibitor  of calcium  currents,  and  racemic  Bay  K  8644,  a 
potentiator of calcium currents. 
Ic~r, is considerably more sensitive to block by (+)-PN 200-110 than is Ic~ (Fig. 
6, A-C).  Altogether,  in  10 dysgenic myotubes held at  -80  mV,  100  nM  (+)-PN 
200-110 reduced peak Ic~-00~ by 76  +  3%.  In contrast, in  11  normal myotubes also 
held at -80  mV, this same concentration of (+)-PN 200-110 only reduced peak Ic~ 
by 27 +  2%. The responses of I~.d~ and Ic~ to (+)-PN 200-110 are summarized by 
Fig. 6 C. The effect of 100 nM (+)-PN 200-110 was completely reversible; washout 
of the drug-containing solution restored Ic~-d~ or Ic~ to within  10% of its  initial 
value  (data  not  shown).  Higher concentrations  of (+)-PN  200-110  caused  more 
complete block of both currents; Ic_~ and Ic~ were reduced by >90% after expo- 
sure to 0.5 and  1 pM (+)-PN 200-110, respectively. 
Ic~y, is also  more sensitive to potentiation by Bay K  8644  than is  Ic~ (Fig.  6, 
D-F). Altogether, in four dysgenic myotubes held at -80  mV, 500 nM Bay K 8644 
increased peak Ic~,a~ to 318  _+  62% of control values.  In contrast, in nine normal 
myotubes,  also  held  at  -80  mV,  this  same  concentration  of Bay  K  8644  only 
increased peak Ic~., by 24 _+ 4%. The differential responses of Ic~-dy~  and Ic~ to Bay K 436  THE JOURNAL OF GENERAL PHYSIOLOGY ￿9 VOLUME 94 ￿9 1989 
8644 are summarized in Fig. 6 F. Washout of 500 nM Bay K  8644 resulted in com- 
plete recovery of Ic~-d~ or Ic~ (data not shown). For both Ic~  and Ic~, Bay K 8644 
shifted  the  peak  current-voltage  relation  negatively by  ~10  mV.  The  effects  of 
higher concentrations of Bay K  8644 were not systematically examined; however,  1 
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FIGURE 6.  Ic__.~ is more sen- 
sitive to  DHPs  than  Ic.~.  Ic~a 
was  absent  from  the  currents 
illustrated in  this  figure;  thus 
the  kinetics  of  the  currents 
shown  reflect  only  those  of 
Ic~  or Ic~. (A) 100 nM  (+)- 
PN  200-110  blocks  Ic.~.~  by 
~75%. Test pulses to + 10 mV. 
(B)  100  nM  (+)-PN  200-110 
blocks  Ic~  by  -25%.  Test 
pulses  to  +30  inV.  (C)  Aver- 
age responses of Ic~-d~ and Ic~ 
to  100  nM  (+)-PN  200-110. 
Data from  10 dysgenic and  11 
normal  myotubcs.  Error  bars 
indicate  _+SEM. (D)  500  nM 
Bay  K  8644  potentiates  IC~dy~ 
about  threefold.  Shown  are 
the  largest  currents  recorded 
in  the  absence  (test  pulse  to 
+30  mV)  and  presence  (test 
pulse to + 10 mV) of the drug. 
(E) 500 nM Bay K 8644 poten- 
tiates Ic~., by ~25%. Shown are 
the  largest  currents  recorded 
in the absence (+30  mV) and 
presence  of  the  drug  (+20 
mV). The current calibration bar 
corresponds  to  5  nA  for  (E) 
only.  (F) Average responses of 
Ic~.a~ and Ic~, to 500 nM Bay K 8644. Data from four dysgenic and nine normal myotubes. 
Error bars indicate +_SEM. In all cases, HP =  -80  mV.  10 mM Ca  z+  +  2-4 pM TTX.  (A) 
Cell B00E05,  dysgenic myotube,  10 d  in culture; C  =  330  pF. (B)  Cell B00E15,  normal 
myotube, 15 d in culture; C =  370 pF. (D) Cell B00E23, dysgenic myotube. 9 d in culture; 
C  =  200 pF. (E) Cell B00E25, normal myotube, 9 d  in culture; C =  300 pF. 
or 5  pM  Bay K  8644  did not appear to cause greater potentiation of Ic~  or Ic~.s 
than 500  nM Bay K  8644. 
From the results presented above we conclude that Ic~.o. and Ic~.s are distinct cal- 
cium currents  having different kinetics, voltage dependence,  and  pharmacological 
properties.  Table  I  summarizes  the  distinguishing characteristics of Ic~.ay~ and  the 
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Expression  of Ic~#, under Different Conditions 
In dysgenic myotubes grown directly upon untreated culture dishes, Ic_~.~ is usually 
so small that it cannot be easily detected. Measuring I~.~ in these cells requires that 
the leak conductance be very low and that voltage-dependent outward currents be 
completely blocked. Even with such ideal recording conditions, we found that Ic~ 
could be detected in only 50% (16/32)  of dysgenic myotubes grown on untreated 
culture dishes. In these 32 cells (from two different cultures) the average (_+ SEM) 
peak current density of Ic.~m was 0.48  +  0.12 pA/pF (range, 0-2.22), whereas the 
average peak density of Ic~.ft was 2.46  +  0.32  pA/pF  (range, 0-7.4).  The level of 
expression  of Ic,~/, appears  to vary widely among different cultures  of dysgenic 
myotubes, and also appears to vary with the age of the culture. This variable, low- 
level expression of Ic,~m in dysgenic myotubes grown on untreated culture dishes 
may reflect the variable presence of contaminating fibroblasts in our primary cul- 
tures (see below). 
TABLE  I 
Calcium Currents of Skeletal Muscle 
Name  DHP 
Kinetics  Where found  References 
(*)  sensitivity 
Ica.ft  Fast-activating, transient  Very low  Normal, dysgenic  2, 3, 4, 8 
(If,  a) 
ICa.fm  Fast-activating, maintained  Very low  Normal  1, 5, 7 
(lc~.0 
ICa.  s  Slowly activating, main-  High  Normal  1-8 
(Islow)  mined 
ICa.dy  s  Fast-activating, maintained  Very high  Dysgenic  This study 
*Alternative nomenclature shown in parentheses. References: 1. Arreola et al., 1987. 2. 
Beam and Knudson, 1988. 3. Beam et al.,  1986. 4. Cognard et al., 1986a. 5. Cota and 
Stefani, 1986. 6. Donaldson and Beam, 1983. 7. Garcia et al., 1988. 8. Gonoi and Hase- 
gawa, 1988. 
I~y~ was more frequently observed in freshly dissociated muscle fibers from fetal 
or neonatal dysgenic mice (e.g., Fig.  1).  Out of 43 fibers examined, 35 possessed 
measureable Ic~y~. In these 43 fibers the average (__ SEM) peak density of Ic~.r  was 
0.61  _+ 0.08 pA/pF (range, 0-2.12), and the average peak density of Io_ft was 2.76 - 
0.32 pA/pF (range, 0.7-8.82).  We found that dysgenic myotubes grown on a sub- 
strate  of killed fibroblasts  (see Methods)  frequently expressed  Ic~,  sometimes at 
fairly high density. In 86 dysgenic myotubes grown on killed fibroblasts (from nine 
different cultures) the average peak density of Ic~.~ was 1.22  __ 0.19 pA/pF (range, 
0-8.86).  In these same myotubes, the average peak density of Ic~.ft  was 1.62  -+ 0.17 
pA/pF (range, 0-7.24). Of the 86 myotubes examined, 13 expressed only Ica-~ and 
24 expressed only Ic~.ft. 
The type of fibroblasts used to create the culture substrate did not seem to be 
important. We used fibroblasts obtained from three different sources: NIH 3T3 cell 
line,  phenotypically normal littermates of dysgenic mice, and dysgenic mice. The 
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from these different sources were  1.49  _  0.42  pA/pF  (n  =  10  randomly selected 
myotubes),  1.48  _+  0.51  (pA/pF  (n =  5),  and  2.35  -+  0.89  pA/pF  (n =  9),  respec- 
tively. 
Is Ic~ Present in Normal Muscle? 
An  important  question  is whether  Ic.~s  is  present  in  normal  developing skeletal 
muscle, where it could easily escape detection due to the obscuring presence of Ic~.s. 
A  B 
50  ms 
c  D 
50  ms 
FIGURE 7.  Ic.~,m may  not  be 
present in normal muscle. (A) 
Calcium  currents  recorded 
from a normal myotube in the 
absence (control) and presence 
(BK) of 0.5 ~tM Bay K 8644.  In 
both cases, HP =  -80 mV and 
test pulse =  + 20 inV. (B) The 
<  control current is shown scaled 
~"  and  superimposed  upon  the 
current  potentiated by Bay K 
8644.  The  scaling factor  was 
determined as the ratio (poten- 
tiated  current)/(control  cur- 
rent),  measured at the end  of 
the test pulse. (C) Calcium cur- 
rents in a dysgenic myotube, 4 
d  after injection of an expres- 
<  sion plasmid (pCAC6) carrying 
r  cDNA  for  the  rabbit  skeletal 
muscle DHP receptor (Tanabe 
et  al.,  1988).  Shown  are  the 
unpotentiated current (control), and the current after addition (BK) of 0.5 uM Bay K 8644. 
Both Ic~,~ and  Ic~ are present.  HP  =  -80  mV,  test pulses to  +50  mV.  (D) The control 
current illustrated in  C was scaled as described in B  and superimposed upon  the current 
potentiated by 0.5 #M Bay K 8644. The nonsuperimposability of the traces is expected if the 
total calcium current contained a fast-activating component (corresponding to Ic~.d.) that was 
potentiated more by Bay K  8644  than  the slowly-activating component  (corresponding to 
Ic~). (A and B) Cell B00E42,  normal myotube, 11  d  in culture, grown on killed fibroblasts; 
C = 415 pF. 10 mM Ca  2+ +  3 ~aM. (C andD) Cell A00J02, dysgenic myotube, 11 d in culture, 
injected with  rabbit skeletal muscle DHP  receptor cDNA on  day 7;  C = 700  pF.  10  mM 
Ca  2+ +  3 uM T'I'X. 
Because Ic~.  activates much faster than Ic  .... its presence in normal muscle should 
cause  the activation of inward current  to display a  fast initial phase  followed by a 
slower phase due to Ic~.~. We did observe such kinetics in calcium currents recorded 
from normal fetal and neonatal muscle fibers and from normal cultured myotubes, 
but the fast initial phase could always be removed with a  brief (e.g.,  1 s) prepulse to 
-30  mV,  indicating that  it was  due  to  the  presence  of Ic~.ft.  Still,  the  possibility ADAMS AND BEAM  Calcium  Current in Dysgenic Muscle  439 
remained  that  Ic~-d~ Was present  in normal  myotubes at  too low a  density to be 
detected without potentiation. Therefore, we looked for Ic~.a. in the presence of 
racemic Bay K 8644. The following approach was employed. Calcium currents were 
recorded from normal myotubes grown on a  substrate of killed fibroblasts. After 
recording control calcium currents, 0.5 or 1 #M Bay K 8644 was added to the exter- 
nal solution (Fig.  7 A). Because Ic~.dr, is greatly potentiated by this compound and 
Ic~_~ is not (Fig. 6 F), currents recorded after the addition of Bay K 8644 should have 
altered activation kinetics if Ic~m were present at significant levels. Such an alter- 
ation in activation kinetics should be revealed by the nonsuperimposability of scaled 
control and potentiated currents. However, application of this test to eight different 
normal myotubes showed that the scaled control current superimposed accurately 
upon the current potentiated by Bay K 8644 (Fig. 7 B). 
As described by Tanabe et al. (1988), injection of an expression plasmid (pCAC6) 
carrying cDNA that encodes the rabbit skeletal muscle DHP receptor into develop- 
ing dysgenic myotubes restores both Ic~ and E-C coupling. In one instance, such an 
injected dysgenic myotube expressed both Ic~., and a  prominent  Ic~r~ (Fig.  7 C). 
Even in the absence of Bay K 8644,  I~.a~ imparted a rapid initial phase to the cur- 
rent that could not be removed by a brief prepulse. In the presence of Bay K 8644, 
Ic~-d~ was  potentiated  to  a  greater  degree  than  Ic~,  and  the  rapid  initial phase 
became  even  more  prominent.  The  predicted  change  in  activation kinetics  (dis- 
cussed above) became very apparent once the control current was scaled and super- 
imposed upon the potentiated current (Fig. 7  D). 
How small would Ic~-d~ have  to be  to escape  detection in  normal  muscle? To 
address this question, we modeled calcium currents that contained two components, 
one having time course and sensitivity to Bay K 8644 corresponding to Ic~rs, the 
other corresponding to Ic~.,. This analysis indicated that altered activation kinetics 
could be easily detected if Ic~dr, composed only 5% of the current (which in these 
myotubes averaged 17.62 pA/pF) recorded before exposure to Bay K 8644. Thus, 
to have escaped detection in normal muscle, Ic~-~ would have had to be present at 
an average density of <0.88 pA/pF, which is lower than the average density of Ic~. 
(1.22 pA/pF) measured in dysgenic myotubes grown on killed fibroblasts. Although 
these observations are not conclusive, they suggest that Ic~  is absent from normal 
skeletal muscle, or at least present at lower density than in dysgenic skeletal mus- 
cle. 
Relative Calcium Current Densities  in Dysgenic and Normal Muscle 
As mentioned above, in 43 dysgenic (fetal or neonatal) muscle fibers the average 
peak density of I~.d~ was 0.61  +  0.08 pA/pF, and the average peak density of Ic~.ft 
was 2.76  _+ 0.32 pA/pF. For comparison, in 35 normal (fetal or neonatal) fibers the 
average peak density of Ic~., was 6.30  _+  0.57 pA/pF (range,  2.33-17.83)  and the 
average peak density of Ic~f, was 2.24  +  0.25 pA/pF (range, 0.47-6.35).  Thus, for 
cells  that have developed entirely in vivo,  Ic~-dr~ in  dysgenic muscle is  present  at 
roughly 10-fold lower density than is Ic~ in normal muscle. In contrast, the densi- 
ties of Ic~.f, are nearly equal in freshly dissociated dysgenic and normal muscle. 
In 86 dysgenic myotubes grown on killed fibroblasts the average peak density of 
Ic~r~ was 1.22  _+ 0.19 pA/pF and the average peak density of Ice.f, was 1.62  + 0.17 440  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  94  ￿9  1989 
pA/pF. Again for comparison, in 31  normal myotubes (from six different cultures 
grown on killed fibroblasts) the average peak density of Ic~ was 14.24  _+  1.08 pA/ 
pF (range, 3.47-26.13) and the average peak density of Ic~.t~ was 3.70  +_ 0.82 pA/pF 
(range,  0-18.82).  Thus,  for cells that have developed in vitro, Ica~r~ is present at 
roughly 12-fold lower density than is Ic~. This result is in good agreement with the 
10-fold difference that was found for freshly dissociated muscle fibers. 
DISCUSSION 
Comparison of Ic~.~ with Other Calcium Currents 
The present results characterize a  previously undescribed calcium current in dys- 
genie skeletal muscle. This current,  Ic~.d~, is kinetically and pharmacologically dis- 
tinct from the L-type calcium current (Ic~) of normal skeletal muscle: it has faster 
activation kinetics, it activates over a more negative range of membrane potentials, 
inactivates over a more positive range of membrane potentials, and it is severalfold 
more sensitive to DHP compounds than Ic~. In addition, the permeability charac- 
teristics of the calcium channel responsible for Ic~y~ are different from those of the 
channel responsible for Ic~, because the amplitude of Ic~  is doubled by substitut- 
ing Ba for Ca in the external medium (Fig. 3), while the amplitude of Ic~ is affected 
little or not at all (Donaldson and Beam, 1983; Beam and Knudson, 1988). 
Ic~  has  kinetics  that  are  very similar to  a  calcium  current  (Ic~.fm) previously 
described  for frog skeletal  muscle  fibers  (Cota  and  Stefani,  1986),  and recently 
reported for rat and rabbit skeletal muscle fibers (Garcia et al.,  1988).  However, 
these two calcium currents respond very differently to dihydropyridine drugs. ICa-dy~ 
of dysgenic skeletal muscle is very sensitive to DHPs (Fig.  6), whereas Ic,.fm of nor- 
real skeletal muscle is insensitive to DHP calcium channel blockers (Arreola et al., 
1987; Garcia et al.,  1988). Thus, based on their different pharmacological proper- 
ties, we conclude that Ic~. and Ic~.fm  are distinct currents. 
Taken together, the pharmacological and kinetic data support  the idea that at 
least three different calcium currents (Ic~.ft, Ic~.fm, and Ic~) are expressed in normal 
skeletal muscle. Additional support for this conclusion is provided by the results of 
Caffrey et al. (1987,  1988) for clonal cell lines derived from rodent muscle. Further, 
our present data indicate that dysgenic skeletal muscle expresses a  fourth calcium 
current (Ic~.~) that is distinct from Ic~ft, Icier, and Ic~ (Table I). 
What type of channel mediates Ice,n? In many respects Ic~  resembles the L-type 
calcium current of cardiac muscle (Bean,  1985).  Ic~  and cardiac L-current have 
similar kinetics, voltage dependence, and sensitivity to DHPs.  Both pass Ba about 
twice as well as Ca. The primary difference between Ic~r, and cardiac L-current is 
that Ic~y~ does not display prominent Ca-dependent inactivation. Thus, even with 
Ca as the charge carrier, Ic~.d~  decays little during a 200 ms test pulse, and the kinet- 
ics of the current are unchanged upon replacement of Ca with Ba (Fig. 3). These 
results suggest that the channel mediating Ic~y~ is distinct from the cardiac L-type 
channel.  However,  the  inactivation  properties  of the  cardiac  channel  might  be 
altered if it were expressed in skeletal muscle. 
The kinetics and voltage-dependence of Ic~y~ also strongly resemble those of neu- 
ronal  L-type calcium current  (Nowycky et al.,  1985;  Fox et al.,  1987).  However, ADAMS  AND BEAM  Calcium  Current in Dysgenic Muscle  441 
unlike Ic,-d~, neuronal L-current elicited from a holding potential of -80 mV is not 
much affected by DHP  calcium channel blockers  (Fox et al.,  1987;  Bean,  1989; 
McCobb et al.,  1989).  A  calcium current in fibroblasts that is potentiated by the 
DHP (+)202-791  (Chen et al., 1988) also has kinetics resembling Ic~.a~. It cannot be 
stated whether the fibroblast current shows other similarities to Ic~.~ because Chen 
et al. (1988) did not report whether this current shows calcium-dependent inactiva- 
tion  or is sensitive to  DHP  calcium channel blockers  at negative holding poten- 
tials. 
Previous experiments have shown that E-C coupling and Ic~ can be restored in 
dysgenic myotubes by co-culture with pure populations of living, nondysgenic fibro- 
blasts; dysgenic fibroblasts are ineffective (Courbin et al.,  1989).  This "rescue" of 
dysgenic muscle appears  to  require  the  fusion of living fibroblasts with cultured 
myotubes (Chaudhari et al.,  1988).  As a  control for these co-culture experiments, 
dysgenic myotubes were grown on a layer of killed fibroblasts. As reported here, the 
expression of Ic~-dr, is enhanced in dysgenic myotubes grown on substrates of killed 
fibroblasts from either normal or dysgenic mice. It should be emphasized that dys- 
genic myotubes grown on killed fibroblasts do not exhibit restored  E-C coupling 
(see below) or the Ic~, characteristic of normal muscle. 
The mechanism by which a substrate of killed fibroblasts enhances the expression 
of  Ic_~.~ remains  uncertain.  Presumably  the  fibroblasts  provide  an  extracellular 
matrix resembling that present during muscle development in vivo because Ic~y, is 
frequently present in acutely dissociated dysgenic muscle fibers. A similar extracel- 
lular environment may be present to a lesser extent in conventional cultures (grown 
directly on plastic dishes) in which dysgenic fibroblasts have proliferated; such an 
occurrence may explain the report of Bournaud et al. (1988) of "partial restoration 
of the slow calcium current" in aged cultures of dysgenic myotubes, and may also 
explain  why we  occasionally recorded  Ic~.~  from  dysgenic myotubes  grown  on 
untreated culture dishes. Beam et al. (1986) did not describe a calcium current in 
dysgenic myotubes corresponding to Ic~,  probably because their myotubes were 
grown directly on untreated culture dishes in the absence  of fibroblasts.  Experi- 
ments are currently underway to further clarify the relationship between develop- 
mental substrate and the expression of Ic~-dw 
Biological  Implications of Ic,~ 
Recent experiments have shown that E-C coupling and Ic~ can be restored in dys- 
genic skeletal muscle by injecting, into myotubes in culture, cDNA for the normal 
skeletal  muscle  DHP  receptor  (Tanabe  et  al.,  1988).  These  results  support  the 
hypothesis (Rios and Brum, 1987) that this DHP receptor has a dual function, serv- 
ing both as the Ic~ calcium channel and as the voltage sensor for E-C coupling. 
Because Ic~  presumably reflects the presence of an L-type calcium channel, in the 
same  class as  the channel that  mediates Ic~,  it is  reasonable  to ask whether the 
channel responsible for Ic~  could also serve in skeletal muscle E-C coupling. Sev- 
eral lines of evidence suggest that it cannot. The presence of Iced. is not correlated 
with the restoration of E-C coupling in dysgenic skeletal muscle. Dysgenic myotubes 
may express Ic~m (this study), yet do not have functional E-C coupling (Powell and 
Fambrough,  1973; Klaus et al.,  1983).  Furthermore, dysgenic myotubes grown on 442  THE JOURNAL OF GENERAL PHYSIOLOGY - VOLUME 94 ￿9 1989 
killed fibroblasts sometimes express Ic~-d~ at high densities (up to 8.86 pA/pF, well 
within the range of magnitudes observed for Ic~_, in normal myotubes; Fig. 4 A) yet 
these same myotubes lack normal E-C coupling. The presence of Ic~,~ in dysgenic 
skeletal muscle, in the absence of E-C coupling, suggests that not all L-type calcium 
channels are equivalent in their ability to couple skeletal muscle excitation to con- 
traction.  E-C  coupling in skeletal muscle apparently requires  the presence of the 
specific DHP receptor that is associated with, and perhaps mediates, Ic~.s. 
One possibility raised by our results is that the channels underlying Ic~r~ consti- 
tute the DHP-binding sites reported for dysgenic skeletal muscle. Although fivefold 
lower than for normal  muscle, the number of high-affinity DHP-binding sites in 
dysgenic muscle is still substantial (Pincon-Raymond et al.,  1985).  Previous to the 
discovery of Ic~d~, it had seemed puzzling that dysgenic skeletal muscle, which com- 
pletely lacks Ic,_~, could still bind DHPs. 
The genetic origin of Ic~  remains unclear. One possibility is that the ICa_dy  ~ chan- 
nel is  the product of a  gene that is  silent in normal skeletal muscle but becomes 
expressed as a result of the muscular dysgenesis mutation. For example, the pres- 
ence of Ic~., might suppress the expression of Ic,~. The simultaneous presence of 
both Ica~ and Ic~.~ in the pCAC6-injected dysgenic myotube shown in Fig. 7 C does 
not necessarily eliminate this as a possibility. Even if Ic~_~ does suppress the expres- 
sion of Ic~_~, there might not have been a sufficient length of time after the injec- 
tion to have eliminated preexisting Ic_~_~ channels. Alternatively, Ic~.0~ may repre- 
sent expression of a  mutated gene for the skeletal muscle DHP receptor.  Restric- 
tion-fragment analysis indicates that the structural gene for this protein is altered in 
muscular dysgenesis; in addition, a low level of mRNA related to the skeletal muscle 
DHP receptor may be present in dysgenic muscle (Tanabe et al.,  1988).  Whatever 
the source of Ic~,, it will be important to determine the primary sequence of the 
protein responsible for this current. Because E-C coupling is nonfunctional in dys- 
genic muscle, differences in  the primary sequences of the Ica-~ and Ic~.~ calcium 
channels may reveal those regions of the protein necessary for E-C coupling. 
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